Rapport Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Rapport Therapeutics is a biotechnology research company focused on developing precision medicines for neurological and psychiatric disorders. It aims to improve efficacy and reduce adverse effects by precisely targeting disease-driving neurocircuits through receptor-associated proteins. Launched in March 2023, the company emerged from a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. Based in Boston, Massachusetts and San Diego, California, Rapport operates within the clinical-stage biotechnology sector, developing small molecule therapies. A recent development includes the June 2026 announcement of a seizure drug Solo.